Treatment with NAD+ precursors of AD mouse models can alleviate several features of AD including Aβ and Tau pathologies, neuroinflammation, cognitive impairments, and synaptic dysfunction, at least partially, through activation of mitophagy, thereby preventing the cells from accumulating damaged mitochondria [145,148]. This evidence concerns the gene MAPT and Alzheimer disease.